RTX Induction and Maintenance in Older ANCA–Associated Vasculitis Patients A cohort study suggests that RTX use among patients 75 years and older with ANCA–associated vasculitis (AAV) is efficacious but also has a high risk of serious adverse events. https://t.co/HF9hyQcHZV https://t.co/xpDSohFcRK